Appearing on NBC's ''Meet the Press,'' Thompson said the more than 60 embryonic stem cell lines identified by the National Institutes of Health are enough to achieve the basic research needed to continue pursuing cures for juvenile diabetes, Parkinson's, Alzheimer's and other diseases.